89 /100
CRITICAL RISK
Score updated May 16, 2026

CLDI — Calidi Biotherapeutics, Inc. Dilution Risk Tracker

Track CLDI dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track CLDI — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
60
💰 Cash Runway
85
📊 Float Risk
50
⚠️ Warrant Exposure
90
🔄Convertible Debt

🌦️ Dilution Forecast

⛈️
Warning
High probability of dilution event
65%
🔄 Reverse Split 70%
• 50-day avg $0.26 below $1 exchange minimum
• Only 6 months cash — financial pressure
📜 Warrant Exercise 60%
• Massive warrant overhang: 325% of shares outstanding
• Warrant risk score very high (90/100)
🔁 Convertible Conversion 60%
• Major convertible overhang: 63% potential dilution
• Convertible risk score very high (85/100)
🔔 Track CLDI — Get forecast alerts →

💹 Market Data

Market Cap$2.83M
Shares Outstanding15.23M
Float10.72M
Cash$5.60M
Debt$2.56M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 112.0% shares (2025Q4 vs prior)
27 institutional holders · 448.4K shares
#1 DRW Securities, LLC 147.8K shares
#2 HighTower Advisors, LLC 83.5K shares
#3 GEODE CAPITAL MANAGEMENT, LLC 41.9K shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest3.04M
Days to Cover1.0
% of Float28.4%
FINRA data as of Apr 30, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Mar 31, 2026
xbrl XBRL CONVERTIBLE Dec 31, 2024
Full SEC filing analysis available with free account

📰 Recent News

No recent news
Track CLDI Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking CLDI — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for CLDI
📊 CLDI FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 CLDI Signal Convergence & Dark Pool Activity — StonkWhisper 📄 CLDI Dilution Risk Analysis — Full In-Depth Report

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.